Latest News & Features
Big Pharma
A medical aid non-profit organisation has opposed a European patent held by pharmaceutical company Gilead that covers its anti-hepatitis C drug Sovaldi. 11 February 2015
Americas
Bayer’s animal health division has filed for a declaratory judgment that SHP Chemical has infringed three patents covering a range of products that control fleas affecting cats and dogs. 9 February 2015
Americas
Law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has bolstered its life sciences practice again, adding a group of five lawyers to its Washington, DC office. 6 February 2015
Americas
US pharmaceutical company Pfizer has agreed to buy drug company Hospira, in an acquisition that will include its biosimilar portfolio. 6 February 2015
Americas
Law firm Kilpatrick Townsend & Stockton has added a chemistry and life sciences team to its Washington, DC office. 4 February 2015
Asia
Another party has thrown its hat into the ring in the fight to stop the issue of an Indian patent covering Sovaldi, a hepatitis C drug. 4 February 2015
Americas
Bayer and Onyx Pharmaceuticals have sued generic drug maker Mylan in an attempt to stop it from developing a version of liver cancer drug Nexavar. 3 February 2015
Americas
Pharmaceutical company Eli Lilly has reported that its US revenue in 2014 dipped by 29% compared to the previous year, laying the blame on key patents, including those for Cymbalta and Evista, expiring. 3 February 2015
Americas
The US Federal Trade Commission has given the green light for Sun Pharmaceutical to merge with Indian generic drug maker Ranbaxy for $4 billion. 2 February 2015
Americas
AstraZeneca has sued Glenmark Pharmaceuticals for allegedly infringing four patents protecting its breast cancer drug Faslodex. 2 February 2015